Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

per Bressler, Susan B., Liu, Danni, Glassman, Adam R., Blodi, Barbara A., Castellarin, Alessandro A., Jampol, Lee M., Kaufman, Paul L., Melia, Michele, Singh, Harinderjit, Wells, John A.
Publicat a JAMA Ophthalmol (2017)

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

per Avery, Robert L, Castellarin, Alessandro A, Steinle, Nathan C, Dhoot, Dilsher S, Pieramici, Dante Joseph, See, Robert, Couvillion, Stephen, Nasir, Ma'an A, Rabena, Melvin D, Le, Kha, Maia, Mauricio, Visich, Jennifer E
Publicat a Br J Ophthalmol (2014)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

per Avery, Robert L., Castellarin, Alessandro A., Steinle, Nathan C., Dhoot, Dilsher S., Pieramici, Dante J., See, Robert, Couvillion, Stephen, Nasir, Ma'an A., Rabena, Melvin D., Maia, Mauricio, Van Everen, Sherri, Le, Kha, Hanley, William D.
Publicat a Retina (2017)

Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials

per Maguire, Maureen G., Daniel, Ebenezer, Shah, Ankoor R., Grunwald, Juan E., Hagstrom, Stephanie A., Avery, Robert L., Huang, Jiayan, Martin, Revell W., Roth, Daniel B., Castellarin, Alessandro A., Bakri, Sophie J., Fine, Stuart L., Martin, Daniel F.
Publicat 2013